| Reduction of spastic hypertonia in patients with spinal cord injury: a double-blind comparison of intravenous orphenadrine citrate and placebo. | |
| | |
MedLine Citation:
|
PMID: 7605186 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
Spasticity is one of the major problems affecting the outcome of rehabilitation in paraplegic patients. Orphenadrine citrate possesses an effective muscle relaxant action in many pathologies. Nevertheless, despite a recognized central site of action, no controlled data are available on its use in the treatment of spastic hypertonia in patients with spinal cord injuries. Therefore, the effect of intravenous administration of 60mg of orphenadrine citrate versus placebo on spastic hypertonia after spinal cord injury was studied in 11 patients. The threshold of the flexion reflex of the lower limb was studied as a neurophysiological correlate of spastic hypertonia. Clinical assessment was made using the Ashworth Spasticity Scale. The threshold, expressed in mAmp, was studied for 60 minutes after the treatment. A significant difference was found using the active drug compared with placebo (p < 0.0001). In 9 patients, the reduction of the abnormal flexion responses after orphenadrine appeared to begin only after 30 minutes. In one patient the onset of the therapeutic effect was early but weak. One patient with severe spastic hypertonia leading to triple flexion when the limb was manipulated did not gain any relief with orphenadrine. The clinical and neurophysiological results suggest an efficacy of orphenadrine citrate in the control of spastic hypertonia in paraplegics. This could be relevant in the rehabilitation strategy, although further studies are needed on the duration of its action. |
| | |
Authors:
|
R Casale; C J Glynn; M Buonocore |
Related Documents
:
|
15838526 - Validity of the detection of wheelchair propulsion as measured with an activity monitor... 1623846 - Electrophysiological assessment of spinal cord lesions by means of transcranial cortica... 8493036 - Preclinical trial of 4-aminopyridine in patients with chronic spinal cord injury. 663766 - Occurrence of cold agglutinins in congenital scoliosis. 20398186 - Twelve-month outcomes and predictors of very stable inr control in prevalent warfarin u... 23164686 - Video capsule endoscopy in patients with nonresponsive celiac disease. |
Publication Detail:
|
Type: Clinical Trial; Controlled Clinical Trial; Journal Article |
Journal Detail:
|
Title: Archives of physical medicine and rehabilitation Volume: 76 ISSN: 0003-9993 ISO Abbreviation: Arch Phys Med Rehabil Publication Date: 1995 Jul |
Date Detail:
|
Created Date: 1995-08-10 Completed Date: 1995-08-10 Revised Date: 2004-11-17 |
Medline Journal Info:
|
Nlm Unique ID: 2985158R Medline TA: Arch Phys Med Rehabil Country: UNITED STATES |
Other Details:
|
Languages: eng Pagination: 660-5 Citation Subset: AIM; IM |
Affiliation:
|
Foundation Clinica del Lavoro, Rehabilitation Center of Montescano, Italy. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Adult Cross-Over Studies Double-Blind Method Female Humans Injections, Intravenous Leg / physiopathology Male Muscle Hypertonia / drug therapy*, physiopathology Muscle Spasticity / drug therapy, physiopathology Orphenadrine / administration & dosage, therapeutic use* Placebos Spinal Cord Injuries / physiopathology* |
| Chemical | |
Reg. No./Substance:
|
0/Placebos; 83-98-7/Orphenadrine |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Feedback-based training of grip force control in patients with brain damage.
Next Document: Temperature-modulated pressure ulcers: a porcine model.